Answers are grounded in this paper and cite their sources.
Here, we present a CRISPR-Cas9 protocol for generating both small indels and multi-kilobase deletions to enable genome editing in human induced pluripotent stem cells (iPSCs). We describe steps for a ribonucleoprotein (RNP)-based approach that integrates guide RNA selection, electroporation, and multi-tiered screening to accurately identify indels, deletions, inversions, and mixed genotypes. Human iPSCs provide a versatile genome editing platform due to their capacity for clonal expansion and differentiation. This protocol provides a scalable framework for genome editing and quality control. For complete details on the use and execution of this protocol, please refer to Hamerlinck et al. 1 1. Hamerlinck, L. ∙ D’haene, E. ∙ Vaughan, M.B. ... Non-coding structural variants disrupt FOXG1 transcriptional regulation in early neurodevelopment Nat. Commun. 2026; 17 , 7197 Crossref Scopus (2) PubMed Google Scholar
No takes yet. Share an insight, caveat, or question.
Hamerlinck et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: